Endothelial cell infection and endotheliitis in COVID-19

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3

Horton, 2020, Offline: COVID-19—bewilderment and candour, Lancet, 395

Ferrario, 2005, Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2, Circulation, 111, 2605, 10.1161/CIRCULATIONAHA.104.510461

Monteil, 2020, Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell, 10.1016/j.cell.2020.04.004

Flammer, 2012, The assessment of endothelial function: from research into clinical practice, Circulation, 126, 753, 10.1161/CIRCULATIONAHA.112.093245

Bonetti, 2003, Endothelial dysfunction - a marker of atherosclerotic risk, Arterioscl Throm Vas, 23, 168, 10.1161/01.ATV.0000051384.43104.FC

Anderson, 1995, The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion, N Engl J Med, 332, 488, 10.1056/NEJM199502233320802

Taddei, 1998, Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients, J Hypertens, 16, 447, 10.1097/00004872-199816040-00006

Flammer, 2008, Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis, Circulation, 117, 2262, 10.1161/CIRCULATIONAHA.107.734384

Hurlimann, 2002, Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis, Circulation, 106, 2184, 10.1161/01.CIR.0000037521.71373.44

Feldmann, 2020, Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed, Lancet, 10.1016/S0140-6736(20)30858-8